No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1r8nA, 0.6931, 2.57, 0.189, 185, 132, THE CRYSTAL STRUCTURE OF THE KUNITZ (STI) TYPE INHIBITOR FROM SEEDS OF DELONIX REGIA
2, 3iirA, 0.6899, 3.13, 0.167, 190, 138, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
3, 3iirB, 0.6896, 3.13, 0.167, 190, 138, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
4, 2wbcA, 0.6831, 2.34, 0.133, 183, 128, REFINED CRYSTAL STRUCTURE (2.3 ANGSTROM) OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR AND LOCATION OF ITS SECOND REACTIVE SITE
5, 1fn0A, 0.6789, 2.43, 0.141, 177, 128, STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14D.
6, 1fmzA, 0.6779, 2.45, 0.125, 179, 128, CRYSTAL STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14K.
7, 4h9wA, 0.6767, 2.47, 0.125, 177, 128, CRYSTAL STRUCTURE OF A METHIONINE MUTANT OF WCI
8, 1eylA, 0.6762, 2.48, 0.141, 179, 128, STRUCTURE OF A RECOMBINANT WINGED BEAN CHYMOTRYPSIN INHIBITOR
9, 4wbcA, 0.6759, 2.68, 0.140, 179, 129, 2.13 A STRUCTURE OF A KUNITZ-TYPE WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
10, 3zc9A, 0.6749, 3.04, 0.172, 182, 134, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 4.6
11, 1wbcA, 0.6747, 2.60, 0.132, 183, 129, CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF PSOPHOCARPIN B1 A CHYMOTRYPSIN INHIBITOR FROM WINGED BEAN SEEDS
12, 3zc8A, 0.6745, 3.05, 0.172, 182, 134, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 7.0
13, 3i2aA, 0.6724, 2.39, 0.126, 180, 127, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
14, 3qydB, 0.6709, 2.53, 0.125, 177, 128, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
15, 3s8jB, 0.6704, 3.09, 0.152, 181, 132, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
16, 3i29B, 0.6675, 2.40, 0.135, 175, 126, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN MUTANT TRYPSIN INHIBITOR WITH BOVINE TRYPSIN
17, 2bebB, 0.6675, 2.41, 0.143, 173, 126, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
18, 3qydC, 0.6669, 2.60, 0.125, 177, 128, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
19, 5yh4A, 0.6668, 2.86, 0.192, 179, 130, MIRACULIN-LIKE PROTEIN FROM VITIS VINIFERA 
20, 2et2A, 0.6667, 2.44, 0.143, 175, 126, CRYSTAL STRUCTURE OF AN ASN TO ALA MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
21, 3s8kA, 0.6656, 3.09, 0.165, 183, 133, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
22, 2iwtB, 0.6645, 2.63, 0.150, 181, 127, THIOREDOXIN H2 (HVTRXH2) IN A MIXED DISULFIDE COMPLEX WITH THE TARGET PROTEIN BASI
23, 2qyiB, 0.6643, 2.45, 0.127, 175, 126, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
24, 4tlpA, 0.6641, 2.62, 0.117, 175, 128, CRYSTAL STRUCTURE OF A ALANINE91 MUTANT OF WCI
25, 2esuA, 0.6640, 2.45, 0.143, 173, 126, CRYSTAL STRUCTURE OF ASN TO GLN MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
26, 3s8kB, 0.6633, 3.06, 0.145, 182, 131, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
27, 3s8jA, 0.6630, 3.08, 0.153, 182, 131, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
28, 2qyiD, 0.6630, 2.54, 0.134, 175, 127, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
29, 4ha2A, 0.6620, 2.52, 0.127, 174, 126, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
30, 3qydA, 0.6619, 2.61, 0.118, 177, 127, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
31, 3veqA, 0.6618, 2.45, 0.135, 175, 126, A BINARY COMPLEX BETWWEN BOVINE PANCREATIC TRYPSIN AND A ENGINEERED MUTANT TRYPSIN INHIBITOR
32, 3i2aB, 0.6599, 2.51, 0.127, 180, 126, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
33, 5dssB, 0.6596, 2.93, 0.177, 185, 130, MP-4 CONTRIBUTES TO SNAKE VENOM NEUTRALIZATION BY MUCUNA PRURIENS SEEDS THROUGH STIMULATION OF CROSS-REACTIVE ANTIBODIES
34, 3i2xA, 0.6596, 2.88, 0.124, 178, 129, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
35, 1avaC, 0.6588, 2.52, 0.151, 181, 126, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
36, 4ha2B, 0.6562, 2.49, 0.128, 173, 125, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
37, 2beaA, 0.6552, 2.37, 0.130, 170, 123, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
38, 3bx1D, 0.6540, 2.55, 0.152, 181, 125, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
39, 2beaB, 0.6537, 2.36, 0.130, 170, 123, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
40, 1avaD, 0.6532, 2.60, 0.143, 181, 126, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
41, 3bx1C, 0.6530, 2.69, 0.151, 181, 126, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
42, 4an6B, 0.6512, 2.38, 0.195, 171, 123, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
43, 2dreC, 0.6508, 2.78, 0.069, 177, 130, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
44, 2bebA, 0.6506, 2.43, 0.138, 170, 123, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
45, 5dvhA, 0.6489, 3.19, 0.134, 185, 134, STRUCTURE OF THE KUNITZ-TYPE CYSTEINE PROTEASE INHIBITOR PCPI-3 FROM POTATO
46, 1z0hB, 0.6484, 3.37, 0.058, 438, 138, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
47, 1z0hA, 0.6481, 3.54, 0.057, 438, 140, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
48, 5yczA, 0.6480, 2.79, 0.127, 178, 126, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
49, 6nttB, 0.6474, 2.62, 0.136, 176, 125, X-RAY CRYSTAL STRUCTURE OF SOYBEAN TRYPSIN INHIBITOR (KUNITZ) COMPLEXED WITH 1;5-DISULFONYL NAPHTHALENE 
50, 1s0dA, 0.6465, 3.42, 0.058, 1287, 138, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
51, 1f31A, 0.6456, 3.43, 0.058, 1280, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE
52, 1tieA, 0.6455, 2.44, 0.116, 166, 121, CRYSTAL STRUCTURE OF A KUNITZ-TYPE TRYPSIN INHIBITOR FROM ERYTHRINA CAFFRA SEEDS
53, 2dreD, 0.6453, 2.88, 0.077, 177, 130, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
54, 1g9cA, 0.6443, 3.34, 0.058, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
55, 1i1eA, 0.6439, 3.43, 0.058, 1287, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
56, 6nttA, 0.6428, 2.64, 0.153, 175, 124, X-RAY CRYSTAL STRUCTURE OF SOYBEAN TRYPSIN INHIBITOR (KUNITZ) COMPLEXED WITH 1;5-DISULFONYL NAPHTHALENE 
57, 1g9aA, 0.6423, 3.46, 0.058, 1287, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
58, 1s0eA, 0.6420, 3.36, 0.058, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
59, 1s0cA, 0.6419, 3.37, 0.058, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
60, 1g9bA, 0.6418, 3.46, 0.058, 1287, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
61, 5xozB, 0.6414, 3.13, 0.160, 179, 131, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
62, 1g9dA, 0.6414, 3.47, 0.058, 1287, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
63, 1s0bA, 0.6411, 3.36, 0.058, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
64, 1epwA, 0.6408, 3.37, 0.058, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
65, 4ii0B, 0.6406, 2.50, 0.130, 163, 123, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
66, 4ihzA, 0.6400, 2.56, 0.138, 163, 123, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
67, 4ii0A, 0.6397, 2.57, 0.129, 163, 124, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
68, 1avuA, 0.6396, 2.70, 0.129, 172, 124, TRYPSIN INHIBITOR FROM SOYBEAN (STI)
69, 3i2xB, 0.6390, 2.97, 0.107, 181, 131, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
70, 5yczB, 0.6384, 2.83, 0.121, 172, 124, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
71, 4ihzB, 0.6382, 2.59, 0.130, 163, 123, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
72, 1s0gA, 0.6381, 3.41, 0.058, 1288, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
73, 1avwB, 0.6380, 2.60, 0.130, 171, 123, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR ORTHORHOMBIC CRYSTAL FORM
74, 5hpzB, 0.6369, 2.74, 0.104, 175, 125, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
75, 5mk6A, 0.6368, 3.43, 0.066, 421, 137, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 1)
76, 5xozA, 0.6367, 3.16, 0.154, 178, 130, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
77, 5hpzA, 0.6362, 2.67, 0.111, 175, 126, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
78, 1ba7B, 0.6361, 2.55, 0.139, 169, 122, SOYBEAN TRYPSIN INHIBITOR
79, 5vidD, 0.6359, 3.41, 0.058, 420, 137, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
80, 2np0A, 0.6356, 3.49, 0.058, 1289, 138, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
81, 2dreB, 0.6355, 2.86, 0.087, 173, 127, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
82, 6g5gB, 0.6342, 3.44, 0.058, 848, 137, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 2 
83, 5vmrB, 0.6322, 3.28, 0.060, 419, 134, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
84, 5vidB, 0.6320, 3.48, 0.058, 412, 137, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
85, 1avxB, 0.6316, 2.62, 0.131, 172, 122, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR TETRAGONAL CRYSTAL FORM
86, 5tpcA, 0.6311, 3.53, 0.066, 425, 137, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE
87, 3v0bA, 0.6303, 3.50, 0.051, 1280, 137, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
88, 3v0aA, 0.6303, 3.50, 0.051, 1280, 137, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
89, 2vu9A, 0.6301, 3.55, 0.066, 425, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B
90, 4an6A, 0.6300, 2.96, 0.202, 172, 124, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
91, 2vuaA, 0.6300, 3.57, 0.058, 423, 137, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN
92, 6g5fB, 0.6284, 3.57, 0.058, 845, 138, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
93, 5vidC, 0.6282, 3.51, 0.058, 426, 137, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
94, 2nm1A, 0.6282, 3.51, 0.067, 430, 135, STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR
95, 5jlvB, 0.6281, 3.46, 0.059, 425, 135, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
96, 1fv3A, 0.6281, 3.59, 0.088, 451, 137, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
97, 3n7kB, 0.6274, 3.40, 0.104, 421, 135, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
98, 5n0cA, 0.6272, 3.87, 0.101, 1293, 139, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
99, 1fv2A, 0.6264, 3.69, 0.087, 451, 138, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
100, 6g5kB, 0.6262, 3.31, 0.060, 424, 133, CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
101, 1fv3B, 0.6259, 3.58, 0.080, 451, 137, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
102, 3r4uA, 0.6258, 3.48, 0.103, 422, 136, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
103, 6g5kA, 0.6257, 3.33, 0.060, 421, 133, CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
104, 1yynA, 0.6257, 3.71, 0.080, 441, 138, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
105, 6dr2D, 0.6254, 2.92, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
106, 6dr2C, 0.6254, 2.92, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
107, 6dr2B, 0.6254, 2.92, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
108, 6dr2A, 0.6254, 2.92, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
109, 5n0bA, 0.6253, 3.80, 0.094, 1280, 138, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A
110, 5vmrA, 0.6252, 3.33, 0.060, 421, 133, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
111, 5n0cB, 0.6250, 3.78, 0.086, 1286, 139, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
112, 5jlvA, 0.6250, 3.53, 0.059, 425, 136, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
113, 3r4uB, 0.6249, 3.46, 0.110, 422, 136, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
114, 3r4sB, 0.6249, 3.48, 0.103, 424, 136, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
115, 1a8dA, 0.6249, 3.57, 0.080, 452, 137, TETANUS TOXIN C FRAGMENT
116, 3r4sA, 0.6244, 3.47, 0.110, 424, 136, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
117, 2vxrA, 0.6241, 3.58, 0.074, 428, 136, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN
118, 1yxwA, 0.6241, 3.71, 0.088, 441, 137, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
119, 3hmyA, 0.6239, 3.65, 0.080, 442, 137, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2
120, 3hn1A, 0.6236, 3.65, 0.080, 442, 137, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 AND LACTOSE
121, 3n7kA, 0.6234, 3.43, 0.104, 422, 135, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
122, 6draC, 0.6233, 2.95, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
123, 6draB, 0.6233, 2.95, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
124, 6draD, 0.6232, 2.95, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
125, 6draA, 0.6232, 2.95, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
126, 4kbbA, 0.6227, 3.41, 0.060, 417, 133, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
127, 1wbaA, 0.6226, 3.17, 0.143, 171, 126, WINGED BEAN ALBUMIN 1
128, 1diwA, 0.6226, 3.67, 0.088, 441, 136, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE
129, 5vidA, 0.6224, 3.40, 0.060, 415, 133, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
130, 6giwD, 0.6214, 2.66, 0.083, 163, 121, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
131, 1af9A, 0.6214, 3.70, 0.080, 441, 138, TETANUS NEUROTOXIN C FRAGMENT
132, 1dfqA, 0.6212, 3.68, 0.080, 441, 137, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID
133, 3fuoA, 0.6207, 3.62, 0.059, 416, 136, THE CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A
134, 1s0fA, 0.6207, 3.47, 0.060, 1276, 133, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
135, 1d0hA, 0.6204, 3.74, 0.095, 441, 137, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE
136, 6es1A, 0.6197, 3.65, 0.066, 420, 136, CRYSTAL STRUCTURE OF THE BINDING DOMAIN FROM BOTULINUM NEUROTOXIN A2 BOUND TO EXTRACELLULAR DOMAIN OF HUMAN RECEPTOR SV2C 
137, 6gixD, 0.6191, 2.66, 0.091, 163, 121, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
138, 6mu2D, 0.6188, 3.00, 0.048, 2170, 125, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
139, 6mu2C, 0.6188, 3.00, 0.048, 2170, 125, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
140, 6mu2B, 0.6188, 3.00, 0.048, 2170, 125, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
141, 6mu2A, 0.6188, 3.00, 0.048, 2170, 125, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
142, 3rmxB, 0.6188, 3.40, 0.060, 407, 134, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
143, 3obtA, 0.6187, 3.39, 0.060, 412, 134, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID
144, 6dqjD, 0.6186, 2.94, 0.072, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
145, 6dqjC, 0.6186, 2.94, 0.072, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
146, 6dqjB, 0.6186, 2.94, 0.072, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
147, 6dqjA, 0.6186, 2.94, 0.072, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
148, 3rmyB, 0.6185, 3.40, 0.067, 398, 134, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
149, 1dllA, 0.6185, 3.78, 0.080, 441, 138, THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE
150, 3e8lC, 0.6184, 3.15, 0.047, 176, 128, THE CRYSTAL STRUCTURE OF THE DOUBLE-HEADED ARROWHEAD PROTEASE INHIBITOR A IN COMPLEX WITH TWO TRYPSINS
151, 5v38A, 0.6181, 3.46, 0.067, 418, 135, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
152, 6dqsD, 0.6179, 3.14, 0.087, 2192, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
153, 3n7jA, 0.6179, 3.46, 0.075, 405, 134, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
154, 6dqsC, 0.6176, 3.14, 0.087, 2186, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
155, 3rmxA, 0.6176, 3.41, 0.060, 404, 134, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
156, 6dqzC, 0.6175, 3.02, 0.071, 2186, 126, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
157, 3obrA, 0.6174, 3.46, 0.075, 418, 134, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
158, 6dqzD, 0.6172, 3.03, 0.079, 2186, 126, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
159, 4kbbB, 0.6167, 3.32, 0.061, 417, 131, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
160, 3rmyC, 0.6167, 3.43, 0.067, 403, 134, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
161, 6dqsB, 0.6162, 3.17, 0.087, 2186, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
162, 6dqsA, 0.6162, 3.17, 0.087, 2186, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
163, 4fvvA, 0.6161, 3.63, 0.088, 412, 136, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
164, 3uj4A, 0.6161, 3.01, 0.056, 486, 126, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
165, 3rmxC, 0.6156, 3.42, 0.067, 403, 134, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
166, 6dr0C, 0.6155, 3.17, 0.087, 2193, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
167, 3rmyD, 0.6146, 3.45, 0.067, 404, 134, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
168, 3rmyA, 0.6146, 3.47, 0.067, 401, 134, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
169, 3mppG, 0.6146, 3.27, 0.069, 403, 131, BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN
170, 6dqnD, 0.6145, 2.96, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
171, 6dqnC, 0.6145, 2.96, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
172, 6dqnB, 0.6145, 2.96, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
173, 6dqnA, 0.6145, 2.96, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
174, 3uj0B, 0.6142, 3.15, 0.047, 502, 127, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
175, 3v0cA, 0.6141, 3.64, 0.059, 1277, 136, 4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)
176, 3oggA, 0.6138, 3.41, 0.068, 404, 133, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D
177, 3rmxD, 0.6137, 3.49, 0.067, 406, 134, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
178, 5xa1B, 0.6135, 3.17, 0.055, 1257, 127, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
179, 5jmcA, 0.6135, 3.54, 0.068, 420, 133, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
180, 5lr0B, 0.6132, 3.69, 0.102, 412, 137, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
181, 3btaA, 0.6132, 3.67, 0.059, 1277, 136, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
182, 1ba7A, 0.6131, 2.55, 0.144, 165, 118, SOYBEAN TRYPSIN INHIBITOR
183, 6drcD, 0.6128, 3.04, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
184, 6drcC, 0.6128, 3.04, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
185, 6drcB, 0.6128, 3.04, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
186, 6drcA, 0.6128, 3.04, 0.064, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
187, 4j2kB, 0.6128, 2.80, 0.149, 167, 121, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
188, 4isrC, 0.6128, 3.69, 0.088, 413, 137, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
189, 3uj0A, 0.6127, 3.06, 0.056, 502, 126, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
190, 4iqpA, 0.6124, 3.66, 0.059, 419, 136, CRYSTAL STRUCTURE OF HCRA-W1266A
191, 3t8sA, 0.6124, 2.98, 0.072, 501, 125, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
192, 5mk8A, 0.6116, 3.52, 0.068, 421, 133, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
193, 4j2kA, 0.6115, 2.72, 0.124, 168, 121, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
194, 5moyA, 0.6114, 3.26, 0.069, 414, 130, CRYSTAL STRUCTURE OF THE BONT/A2 RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF ITS NEURONAL RECEPTOR SV2C
195, 4isqA, 0.6112, 3.70, 0.088, 414, 136, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
196, 4j2yA, 0.6111, 2.63, 0.144, 165, 118, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI IN COMPLEX WITH BOVINE TRYPSIN.
197, 5x9zA, 0.6110, 2.97, 0.064, 1710, 125, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
198, 3azwA, 0.6109, 3.60, 0.089, 418, 135, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
199, 4uwaD, 0.6108, 2.95, 0.125, 3324, 120, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
200, 4uwaC, 0.6108, 2.95, 0.125, 3324, 120, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
201, 4uwaB, 0.6108, 2.95, 0.125, 3324, 120, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
202, 4uwaA, 0.6108, 2.95, 0.125, 3324, 120, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
203, 4isqC, 0.6106, 3.73, 0.094, 414, 138, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
204, 6gixC, 0.6103, 2.44, 0.085, 161, 117, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
205, 4jraA, 0.6103, 3.64, 0.075, 416, 134, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
206, 5gugA, 0.6101, 3.07, 0.063, 1721, 126, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
207, 5v38B, 0.6099, 3.33, 0.069, 416, 131, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
208, 5mk8B, 0.6099, 3.54, 0.068, 420, 133, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
209, 3n7mA, 0.6098, 3.58, 0.104, 418, 135, CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995
210, 3n7lA, 0.6098, 3.59, 0.096, 418, 135, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN
211, 4f83A, 0.6097, 3.62, 0.067, 413, 134, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE
212, 3malA, 0.6096, 3.57, 0.053, 181, 131, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
213, 5lr0A, 0.6094, 3.71, 0.101, 407, 138, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
214, 4isqB, 0.6093, 3.70, 0.074, 413, 136, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
215, 5jmcC, 0.6091, 3.49, 0.061, 417, 131, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
216, 6f0pA, 0.6090, 3.77, 0.059, 418, 136, BOTULINUM NEUROTOXIN A4 HC DOMAIN
217, 4fvvB, 0.6088, 3.76, 0.087, 415, 138, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
218, 3t8sB, 0.6087, 3.34, 0.055, 482, 127, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
219, 4isrB, 0.6086, 3.69, 0.074, 413, 136, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
220, 4isrA, 0.6084, 3.62, 0.089, 414, 135, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
221, 2nz9A, 0.6084, 3.80, 0.051, 1267, 136, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
222, 3azwB, 0.6083, 3.70, 0.109, 418, 137, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
223, 2nyyA, 0.6081, 3.83, 0.059, 1267, 136, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
224, 5jmcE, 0.6080, 3.42, 0.061, 419, 132, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
225, 2gzbA, 0.6080, 2.81, 0.133, 164, 120, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
226, 5jmcG, 0.6073, 3.55, 0.060, 419, 133, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
227, 6dwuJA, 0.6070, 2.69, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
228, 3malB, 0.6070, 3.54, 0.061, 181, 131, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
229, 5wvxA, 0.6067, 2.38, 0.087, 157, 115, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
230, 1t9fA, 0.6064, 3.15, 0.032, 178, 125, STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION
231, 6dwuD, 0.6061, 2.69, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
232, 2qn4B, 0.6056, 2.73, 0.137, 163, 117, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
233, 6dwuZB, 0.6051, 2.76, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
234, 5gkzE, 0.6051, 2.72, 0.145, 163, 117, 
235, 5gkzC, 0.6051, 2.44, 0.149, 159, 114, 
236, 5gkzA, 0.6051, 2.73, 0.137, 163, 117, 
237, 5gkzG, 0.6050, 3.17, 0.122, 3660, 123, 
238, 6dwuVB, 0.6049, 3.17, 0.122, 3660, 123, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
239, 3pmeA, 0.6049, 3.17, 0.122, 3660, 123, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE
240, 2gzbB, 0.6047, 3.18, 0.122, 3660, 123, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
241, 6dwuT, 0.6046, 2.73, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
242, 6dwuHA, 0.6046, 3.66, 0.060, 415, 133, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
243, 5gkyC, 0.6046, 2.85, 0.133, 163, 120, 
244, 6dwuH, 0.6045, 2.72, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
245, 6dr0D, 0.6045, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
246, 5gkyG, 0.6045, 2.76, 0.137, 163, 117, 
247, 5gkyE, 0.6045, 2.73, 0.137, 163, 117, 
248, 5gkyA, 0.6045, 3.16, 0.130, 3660, 123, 
249, 6dwuNA, 0.6044, 2.73, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
250, 5l21A, 0.6044, 2.73, 0.137, 163, 117, CRYSTAL STRUCTURE OF BONT/A RECEPTOR BINDING DOMAIN IN COMPLEX WITH VHH C2
251, 2nz9B, 0.6042, 2.80, 0.145, 163, 117, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
252, 6dwuJ, 0.6041, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
253, 6dwuFC, 0.6041, 3.19, 0.056, 2181, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
254, 6dwuBC, 0.6040, 3.16, 0.130, 3660, 123, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
255, 5tpbB, 0.6040, 3.16, 0.130, 3660, 123, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
256, 6dqvD, 0.6039, 3.16, 0.130, 3660, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
257, 6dqvC, 0.6039, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
258, 6dqvB, 0.6039, 3.77, 0.045, 425, 134, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
259, 6dqvA, 0.6039, 3.83, 0.059, 1267, 136, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
260, 2qn4A, 0.6038, 2.72, 0.145, 163, 117, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
261, 6dwuXA, 0.6037, 2.69, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
262, 6dwuN, 0.6037, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
263, 6dwuFB, 0.6037, 2.79, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
264, 6dwuRA, 0.6035, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
265, 6dwuLB, 0.6035, 2.72, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
266, 6dr0B, 0.6035, 3.54, 0.069, 407, 130, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
267, 6dwuXB, 0.6033, 3.22, 0.064, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
268, 6dwuL, 0.6033, 3.22, 0.064, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
269, 6dwuV, 0.6032, 3.22, 0.064, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
270, 6dwuNB, 0.6032, 3.22, 0.064, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
271, 6dwuHC, 0.6032, 2.45, 0.149, 159, 114, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
272, 6dwuDC, 0.6032, 2.73, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
273, 6dwuDA, 0.6031, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
274, 6dqzA, 0.6031, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
275, 5xa0A, 0.6031, 2.76, 0.137, 163, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
276, 5tpbA, 0.6030, 2.73, 0.137, 163, 117, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
277, 6dwuLA, 0.6029, 2.74, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
278, 6dwuDB, 0.6029, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
279, 6dqzB, 0.6029, 3.20, 0.056, 2188, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
280, 6dwuX, 0.6028, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
281, 6dwuJB, 0.6028, 2.72, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
282, 1xzzA, 0.6028, 2.75, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 1 INOSITOL 145-TRISPHOSPHATE RECEPTOR
283, 6giwC, 0.6027, 2.74, 0.137, 163, 117, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
284, 6dwuP, 0.6026, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
285, 6dwuZA, 0.6025, 2.82, 0.136, 163, 118, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
286, 6dwuTB, 0.6025, 2.73, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
287, 6dwuBA, 0.6025, 2.76, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
288, 6dwuZ, 0.6023, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
289, 6dwuRB, 0.6023, 2.72, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
290, 5mk7A, 0.6023, 2.73, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 2)
291, 6dwuFA, 0.6022, 3.21, 0.072, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
292, 6dwuBB, 0.6022, 3.20, 0.063, 1252, 126, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
293, 6dwuPA, 0.6020, 3.43, 0.069, 411, 130, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
294, 6dr0A, 0.6019, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
295, 6dwuTA, 0.6018, 2.76, 0.145, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
296, 6dwuB, 0.6018, 3.21, 0.072, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
297, 6dwuF, 0.6017, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
298, 4uweD, 0.6017, 2.73, 0.137, 163, 117, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
299, 4uweC, 0.6017, 2.75, 0.137, 163, 117, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
300, 4uweB, 0.6017, 2.75, 0.137, 163, 117, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
301, 4uweA, 0.6017, 3.22, 0.071, 216, 126, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
302, 2xoaA, 0.6017, 2.40, 0.087, 157, 115, CRYSTAL STRUCTURE OF THE N-TERMINAL THREE DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RYR1)
303, 5x9zB, 0.6014, 2.77, 0.137, 163, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
304, 6dwuR, 0.6009, 2.76, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
305, 3azvA, 0.6008, 2.78, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
306, 4zotA, 0.6007, 2.74, 0.137, 163, 117, CRYSTAL STRUCTURE OF BBKI A DISULFIDE-FREE PLASMA KALLIKREIN INHIBITOR AT 1.4 A RESOLUTION
307, 3azvB, 0.6007, 2.76, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
308, 5xa1A, 0.6001, 2.75, 0.137, 163, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
309, 5gl0E, 0.6001, 2.75, 0.145, 163, 117, 
310, 5gl0C, 0.6001, 2.74, 0.137, 163, 117, 
311, 5gl0G, 0.6000, 2.73, 0.137, 163, 117, 
312, 5gl0A, 0.6000, 2.78, 0.145, 163, 117, 
313, 4an7B, 0.5999, 3.56, 0.061, 397, 131, KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN
314, 2go2A, 0.5995, 2.75, 0.145, 163, 117, CRYSTAL STRUCTURE OF BBKI A KUNITZ-TYPE KALLIKREIN INHIBITOR
315, 6dwuPB, 0.5994, 2.74, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
316, 4jraB, 0.5992, 2.76, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
317, 6dwuVA, 0.5989, 3.22, 0.064, 2188, 125, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
318, 6dwuHB, 0.5989, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
319, 6dwhH, 0.5987, 2.74, 0.137, 163, 117, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
320, 6dwuJC, 0.5984, 2.75, 0.137, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
321, 6dwhG, 0.5983, 2.74, 0.137, 163, 117, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
322, 3jrrA, 0.5983, 2.72, 0.137, 163, 117, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
323, 5go9D, 0.5982, 2.74, 0.137, 163, 117, 
324, 5go9C, 0.5982, 2.75, 0.145, 163, 117, 
325, 5go9B, 0.5982, 2.73, 0.137, 163, 117, 
326, 5go9A, 0.5982, 2.74, 0.137, 163, 117, 
327, 6dwfJ, 0.5981, 3.05, 0.124, 3322, 121, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
328, 6dwhK, 0.5980, 3.05, 0.124, 3322, 121, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
329, 6dwhJ, 0.5978, 3.05, 0.124, 3322, 121, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
330, 6dwfH, 0.5977, 3.05, 0.124, 3322, 121, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
331, 6dwhL, 0.5974, 2.89, 0.127, 461, 118, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
332, 6dwhI, 0.5974, 3.12, 0.063, 1708, 126, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
333, 6dwfK, 0.5974, 2.76, 0.145, 163, 117, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
334, 5goaC, 0.5974, 2.74, 0.145, 163, 117, 
335, 5goaA, 0.5974, 2.78, 0.145, 163, 117, 
336, 6dwfI, 0.5973, 3.62, 0.097, 405, 134, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
337, 5gugB, 0.5973, 2.73, 0.137, 163, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
338, 5goaD, 0.5973, 3.61, 0.112, 405, 134, 
339, 6gixB, 0.5972, 3.50, 0.077, 1257, 130, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
340, 3jrrB, 0.5972, 3.27, 0.114, 3660, 123, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
341, 6dwfG, 0.5969, 3.27, 0.114, 3660, 123, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
342, 4jkqA, 0.5968, 3.27, 0.114, 3660, 123, CRYSTAL STRUCTURE OF THE N-TERMINAL REGION OF THE HUMAN RYANODINE RECEPTOR 2
343, 5goaB, 0.5967, 3.27, 0.114, 3660, 123, 
344, 6giwA, 0.5964, 2.37, 0.193, 156, 114, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
345, 6dwfL, 0.5962, 2.85, 0.136, 163, 118, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
346, 4i1eA, 0.5961, 2.78, 0.137, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT G249R
347, 5gl1G, 0.5959, 3.80, 0.060, 413, 134, 
348, 5gl1E, 0.5958, 2.82, 0.136, 163, 118, 
349, 5gl1A, 0.5958, 2.80, 0.145, 163, 117, 
350, 5gl1C, 0.5957, 2.81, 0.145, 163, 117, 
351, 6gixA, 0.5953, 2.79, 0.145, 163, 117, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
352, 5wvxB, 0.5943, 2.79, 0.145, 163, 117, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
353, 3ffzA, 0.5943, 2.93, 0.091, 216, 121, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
354, 3uj4B, 0.5933, 3.18, 0.065, 3423, 123, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
355, 5xa0B, 0.5928, 3.18, 0.065, 3423, 123, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
356, 5vidE, 0.5922, 3.18, 0.065, 3423, 123, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
357, 4i7iA, 0.5922, 3.18, 0.065, 3423, 123, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT L14R
358, 4l4iA, 0.5921, 2.81, 0.137, 163, 117, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547 DISEASE MUTANT R420Q
359, 6f0oA, 0.5916, 2.80, 0.137, 163, 117, BOTULINUM NEUROTOXIN A3 HC DOMAIN
360, 4i37A, 0.5911, 2.81, 0.145, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT R402G
361, 3rsjD, 0.5906, 2.82, 0.145, 163, 117, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
362, 4i6iA, 0.5901, 2.80, 0.137, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-559) DISEASE MUTANT R45C
363, 4i2sA, 0.5901, 2.79, 0.145, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT I404M
364, 3rsjB, 0.5901, 2.81, 0.137, 163, 117, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
365, 3rsjA, 0.5885, 3.35, 0.081, 3423, 123, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
366, 5l1dG, 0.5884, 3.34, 0.081, 3423, 123, 
367, 5l1dC, 0.5864, 2.82, 0.145, 163, 117, 
368, 6giwB, 0.5858, 3.49, 0.077, 1720, 130, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
369, 5l1dA, 0.5854, 3.35, 0.081, 3423, 123, 
370, 5l1dE, 0.5853, 2.47, 0.087, 158, 115, 
371, 4zktE, 0.5770, 2.93, 0.091, 219, 121, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
372, 4zktA, 0.5768, 2.82, 0.145, 163, 117, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
373, 4zktC, 0.5764, 3.27, 0.032, 499, 124, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
374, 5y9vA, 0.5763, 3.19, 0.082, 3423, 122, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
375, 3fuqA, 0.5732, 2.42, 0.088, 156, 114, GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F
376, 3ilaF, 0.5694, 2.81, 0.137, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
377, 5y9vB, 0.5681, 2.95, 0.127, 484, 118, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
378, 6mu1D, 0.5660, 3.23, 0.106, 3645, 123, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
379, 6mu1C, 0.5660, 3.23, 0.106, 3645, 123, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
380, 6mu1B, 0.5660, 3.23, 0.106, 3645, 123, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
381, 6mu1A, 0.5660, 3.23, 0.106, 3645, 123, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
382, 5fozB, 0.5660, 2.42, 0.088, 157, 114, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
383, 5foyB, 0.5649, 2.40, 0.080, 153, 113, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
384, 3h6qA, 0.5639, 3.21, 0.064, 1246, 125, MACROCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
385, 5g37B, 0.5630, 3.50, 0.069, 490, 130, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
386, 3ilaG, 0.5628, 3.25, 0.040, 1252, 126, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
387, 3pubB, 0.5626, 3.33, 0.072, 405, 125, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
388, 3ilaC, 0.5621, 3.16, 0.133, 485, 120, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
389, 3wa1A, 0.5614, 2.96, 0.033, 473, 120, CRYSTAL STRUCTURE OF BINB: A RECEPTOR BINDING COMPONENT OF THE BINARY TOXIN FROM LYSINIBACILLUS SPHAERICUS
390, 3pubA, 0.5594, 3.68, 0.061, 407, 132, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
391, 3pokA, 0.5592, 3.10, 0.126, 466, 119, INTERLEUKIN-1-BETA LBT L3 MUTANT
392, 4iy9B, 0.5583, 3.31, 0.088, 404, 125, BMLP3 - C2 CRYSTAL FORM
393, 4iy8C, 0.5575, 3.22, 0.125, 451, 120, BMLP3 - P21 CRYSTAL FORM
394, 3v0bB, 0.5574, 3.50, 0.056, 482, 125, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
395, 3v0aB, 0.5574, 3.32, 0.088, 402, 125, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
396, 2vsaA, 0.5555, 3.27, 0.088, 406, 125, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
397, 4iy9A, 0.5551, 3.12, 0.057, 3570, 123, BMLP3 - C2 CRYSTAL FORM
398, 2vseA, 0.5544, 3.14, 0.049, 3570, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
399, 2vseB, 0.5543, 2.42, 0.089, 155, 112, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
400, 5ehaA, 0.5542, 3.16, 0.057, 3570, 123, CRYSTAL STRUCTURE OF RECOMBINANT MTAL AT 1.35 ANGSTROM RESOLUTION
401, 4kekA, 0.5542, 3.17, 0.057, 3570, 123, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R176Q
402, 3qr5B, 0.5542, 3.42, 0.065, 1235, 124, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
403, 5d62A, 0.5540, 3.39, 0.065, 1235, 124, MOA-Z-VAD-FMK COMPLEX INVERTED ORIENTATION
404, 5d63A, 0.5539, 3.40, 0.065, 1235, 124, MOA-Z-VAD-FMK INHIBITOR COMPLEX DIRECT/INVERTED DUAL ORIENTATION
405, 3ilaD, 0.5538, 3.23, 0.058, 177, 120, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
406, 2ihoA, 0.5538, 3.32, 0.082, 399, 122, CRYSTAL STRUCTURE OF MOA A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(13)GAL(14)GLCNAC
407, 4efpA, 0.5536, 3.09, 0.035, 162, 114, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
408, 3qr5A, 0.5535, 3.27, 0.051, 170, 118, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
409, 3ef2D, 0.5535, 3.62, 0.088, 2149, 125, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
410, 3ef2C, 0.5535, 3.62, 0.088, 2149, 125, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
411, 3ef2B, 0.5535, 3.62, 0.088, 2149, 125, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
412, 3ef2A, 0.5534, 3.62, 0.088, 2149, 125, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
413, 4efrA, 0.5532, 3.06, 0.051, 419, 118, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
414, 5mu9A, 0.5529, 3.07, 0.051, 421, 118, MOA-E-64 COMPLEX
415, 5d61A, 0.5529, 3.82, 0.104, 168, 125, MOA-Z-VAD-FMK COMPLEX DIRECT ORIENTATION
416, 4efqA, 0.5527, 3.31, 0.067, 420, 119, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
417, 4efpB, 0.5526, 3.21, 0.044, 160, 114, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
418, 4efrC, 0.5525, 3.17, 0.111, 236, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
419, 1jlxA, 0.5523, 3.26, 0.052, 162, 115, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
420, 4efrB, 0.5521, 3.24, 0.042, 389, 119, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
421, 3ilaA, 0.5521, 3.18, 0.112, 235, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
422, 3javC, 0.5515, 3.62, 0.074, 159, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
423, 3javA, 0.5515, 3.38, 0.093, 235, 118, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
424, 3javD, 0.5514, 3.28, 0.111, 239, 117, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
425, 3javB, 0.5514, 2.91, 0.088, 1150, 113, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
426, 4efrD, 0.5509, 2.91, 0.088, 1150, 113, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
427, 4efqB, 0.5509, 3.23, 0.078, 822, 116, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
428, 3hsmA, 0.5507, 3.30, 0.103, 235, 117, CRYSTAL STRUCTURE OF DISTAL N-TERMINAL BETA-TREFOIL DOMAIN OF RYANODINE RECEPTOR TYPE 1
429, 1s0lA, 0.5506, 3.26, 0.078, 823, 116, INTERLEUKIN 1 BETA MUTANT F42W
430, 1twmA, 0.5499, 3.27, 0.078, 822, 116, INTERLEUKIN-1 BETA MUTANT F146Y
431, 3ilaB, 0.5496, 3.23, 0.115, 153, 113, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
432, 1tweA, 0.5490, 3.28, 0.035, 167, 113, INTERLEUKIN 1 BETA MUTANT F101Y
433, 2i1bA, 0.5489, 3.06, 0.045, 154, 112, CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION
434, 1jlyB, 0.5488, 3.84, 0.081, 292, 123, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
435, 1itbA, 0.5487, 3.84, 0.081, 292, 123, TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA
436, 1jlxB, 0.5485, 3.39, 0.035, 162, 114, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
437, 9ilbA, 0.5482, 3.84, 0.081, 292, 123, HUMAN INTERLEUKIN-1 BETA
438, 1qxmA, 0.5482, 3.20, 0.122, 234, 115, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
439, 4pc4D, 0.5480, 2.70, 0.037, 151, 109, BOMBYX MORI LIPOPROTEIN 6
440, 4i1bA, 0.5477, 3.85, 0.081, 291, 123, FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE
441, 21biA, 0.5477, 3.85, 0.081, 291, 123, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)
442, 5i1bA, 0.5474, 3.85, 0.081, 291, 123, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
443, 1iobA, 0.5473, 3.86, 0.081, 291, 123, INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT
444, 4g6jA, 0.5472, 3.26, 0.112, 234, 116, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
445, 3aj6A, 0.5472, 3.85, 0.081, 292, 123, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
446, 3ah4A, 0.5472, 3.84, 0.081, 292, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
447, 3aj5A, 0.5471, 3.39, 0.103, 234, 117, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
448, 1tooA, 0.5470, 3.28, 0.112, 234, 116, INTERLEUKIN 1B MUTANT F146W
449, 4pc4A, 0.5468, 3.26, 0.103, 235, 116, BOMBYX MORI LIPOPROTEIN 6
450, 3ilaE, 0.5468, 3.55, 0.043, 299, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
451, 3ah1A, 0.5467, 3.21, 0.113, 233, 115, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
452, 2nvhA, 0.5467, 3.22, 0.061, 164, 114, DETERMINATION OF SOLVENT CONTENT IN CAVITIES IN INTERLEUKIN- 1 USING EXPERIMENTALLY-PHASED ELECTRON DENSITY
453, 1jlyA, 0.5466, 3.98, 0.062, 2327, 129, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
454, 4pc4E, 0.5465, 3.98, 0.062, 2327, 129, BOMBYX MORI LIPOPROTEIN 6
455, 2e4mA, 0.5465, 3.98, 0.062, 2327, 129, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
456, 4pc4B, 0.5464, 3.98, 0.062, 2327, 129, BOMBYX MORI LIPOPROTEIN 6
457, 4pc4C, 0.5462, 3.28, 0.103, 233, 116, BOMBYX MORI LIPOPROTEIN 6
458, 3ah2A, 0.5462, 3.29, 0.112, 234, 116, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
459, 1t4qA, 0.5460, 3.18, 0.053, 164, 113, INTERLEUKIN 1 BETA F101W
460, 1i1bA, 0.5459, 3.66, 0.076, 153, 118, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
461, 3ah4B, 0.5456, 3.67, 0.076, 153, 118, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
462, 1tp0A, 0.5456, 3.23, 0.036, 160, 112, TRIPLE MUTATION IN INTERLEUKIN 1 BETA CAVITY:REPLACEMENT OF PHENYLALANINES WITH TRYPTOPHAN.
463, 1qxmB, 0.5448, 3.67, 0.068, 153, 118, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
464, 2kh2A, 0.5446, 3.68, 0.076, 153, 118, SOLUTION STRUCTURE OF A SCFV-IL-1B COMPLEX
465, 4hjjA, 0.5445, 3.59, 0.059, 299, 118, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
466, 2y9xG, 0.5445, 3.62, 0.085, 153, 118, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
467, 41biA, 0.5444, 3.60, 0.059, 299, 118, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)
468, 3aj5B, 0.5443, 3.59, 0.085, 153, 118, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
469, 2y9wD, 0.5440, 3.09, 0.106, 283, 113, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
470, 3aj6B, 0.5439, 3.35, 0.096, 238, 115, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
471, 3hsmB, 0.5438, 3.50, 0.068, 151, 117, CRYSTAL STRUCTURE OF DISTAL N-TERMINAL BETA-TREFOIL DOMAIN OF RYANODINE RECEPTOR TYPE 1
472, 2y9xH, 0.5438, 3.51, 0.068, 151, 117, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
473, 3ilaH, 0.5437, 3.58, 0.077, 151, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
474, 3phzB, 0.5432, 3.63, 0.085, 153, 118, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
475, 6i1bA, 0.5429, 3.36, 0.078, 149, 115, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
476, 2vxtI, 0.5429, 3.10, 0.106, 283, 113, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
477, 2y9xF, 0.5427, 3.10, 0.106, 283, 113, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
478, 5b2hA, 0.5424, 3.10, 0.106, 283, 113, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
479, 2y9wC, 0.5424, 3.58, 0.077, 153, 117, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
480, 3ah2B, 0.5423, 3.36, 0.096, 238, 115, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
481, 2e4mB, 0.5422, 3.11, 0.045, 156, 110, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
482, 5b2hB, 0.5420, 3.08, 0.088, 283, 113, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
483, 2y9xE, 0.5417, 3.51, 0.086, 152, 116, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
484, 3wo2C, 0.5415, 3.69, 0.059, 299, 119, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
485, 5bvpI, 0.5412, 3.36, 0.096, 239, 115, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
486, 31biA, 0.5412, 3.15, 0.097, 285, 113, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)
487, 4g6mA, 0.5409, 3.50, 0.095, 238, 116, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
488, 1hibA, 0.5404, 3.37, 0.096, 240, 115, THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN- PROTEIN RECOGNITION
489, 2mibA, 0.5402, 3.11, 0.106, 283, 113, THE STRUCTURE OF MURINE INTERLEUKIN-1 BETA AT 2.8 ANGSTROMS RESOLUTION
490, 3wo2D, 0.5399, 3.60, 0.068, 153, 117, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
491, 3ltqA, 0.5397, 3.51, 0.085, 151, 117, STRUCTURE OF INTERLEUKIN 1B SOLVED BY SAD USING AN INSERTED LANTHANIDE BINDING TAG
492, 3wo2A, 0.5396, 3.16, 0.106, 285, 113, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
493, 3ah1B, 0.5395, 3.60, 0.068, 153, 117, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
494, 7i1bA, 0.5394, 3.17, 0.115, 283, 113, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
495, 4ekxD, 0.5393, 3.69, 0.085, 153, 118, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
496, 3phzA, 0.5385, 3.45, 0.096, 157, 115, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
497, 5fozA, 0.5384, 2.84, 0.120, 136, 108, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
498, 3o4oA, 0.5384, 3.39, 0.070, 150, 115, CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
499, 2wryA, 0.5377, 3.08, 0.115, 283, 113, CRYSTAL STRUCTURE OF CHICKEN CYTOKINE INTERLEUKIN 1 BETA
500, 4x39A, 0.5373, 2.76, 0.121, 135, 107, GALLUS INTERLEUKIN-1 BETA MUTANT - T117A
501, 4gaiA, 0.5369, 3.18, 0.106, 284, 113, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
502, 3wo3E, 0.5369, 3.04, 0.045, 159, 110, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
503, 8i1bA, 0.5363, 2.76, 0.121, 136, 107, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
504, 3wo4A, 0.5362, 3.15, 0.054, 159, 111, CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX
505, 4gafA, 0.5353, 3.51, 0.051, 278, 118, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA BOUND TO HUMAN INTERLEUKIN-1 RECEPTOR TYPE 1
506, 4x37A, 0.5352, 3.45, 0.060, 153, 116, GALLUS INTERLEUKIN-1 MUTANT - E118K
507, 4r6uD, 0.5351, 3.47, 0.086, 156, 116, IL-18 RECEPTOR COMPLEX
508, 3wo2B, 0.5350, 2.86, 0.120, 136, 108, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
509, 2x2sA, 0.5345, 3.17, 0.106, 283, 113, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
510, 1j0sA, 0.5344, 2.88, 0.120, 136, 108, SOLUTION STRUCTURE OF THE HUMAN INTERLEUKIN-18
511, 3wo3I, 0.5341, 3.22, 0.114, 283, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
512, 1w3gA, 0.5340, 3.20, 0.096, 285, 114, HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH TWO N-ACETYLLACTOSAMINE MOLECULES.
513, 2x2sD, 0.5339, 3.20, 0.114, 283, 114, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
514, 5mvzV, 0.5338, 2.87, 0.120, 136, 108, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
515, 4x38A, 0.5334, 3.48, 0.087, 157, 115, GALLUS INTERLEUKIN-1 BETA MUTANT - E118A
516, 4xfsA, 0.5333, 3.43, 0.079, 149, 114, STRUCTURE OF IL-18 SER MUTANT I
517, 3p6iA, 0.5333, 3.47, 0.070, 149, 115, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  2: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
518, 1w3fA, 0.5333, 3.59, 0.078, 150, 116, CRYSTAL STRUCTURE OF THE HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH N-ACETYLLACTOSAMINE IN THE GAMMA MOTIF
519, 1w3aA, 0.5333, 3.52, 0.086, 150, 116, THREE DIMENSIONAL STRUCTURE OF A NOVEL PORE-FORMING LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS
520, 4i96A, 0.5331, 3.42, 0.096, 149, 114, CRYSTAL STRUCTURE OF THE N-TERMINAL TWO DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RABBIT RYR1) RESIDUES 217-536
521, 3wo3C, 0.5331, 3.52, 0.087, 157, 115, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
522, 4xfsB, 0.5328, 3.74, 0.076, 168, 118, STRUCTURE OF IL-18 SER MUTANT I
523, 3wo3A, 0.5328, 3.51, 0.087, 157, 115, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
524, 4r6uB, 0.5325, 3.20, 0.096, 288, 115, IL-18 RECEPTOR COMPLEX
525, 3snvA, 0.5325, 3.67, 0.085, 153, 118, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
526, 3wo3K, 0.5321, 3.56, 0.096, 155, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
527, 4xftA, 0.5320, 3.37, 0.034, 278, 117, STRUCTURE OF IL-18 SER MUTANT III
528, 3wo3G, 0.5320, 3.15, 0.018, 364, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
529, 3nbeB, 0.5320, 3.73, 0.085, 152, 117, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
530, 4depA, 0.5319, 3.50, 0.105, 154, 114, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
531, 3nbdB, 0.5319, 3.58, 0.096, 154, 115, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
532, 4tlvC, 0.5317, 3.62, 0.026, 152, 116, CARDS TOXIN NICKED
533, 2x2sB, 0.5315, 3.56, 0.096, 157, 115, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
534, 4depD, 0.5314, 3.41, 0.088, 146, 113, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
535, 3snvB, 0.5314, 3.46, 0.096, 157, 114, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
536, 1l2hA, 0.5311, 3.73, 0.026, 152, 117, CRYSTAL STRUCTURE OF INTERLEUKIN 1-BETA F42W/W120F MUTANT
537, 1dzcA, 0.5311, 3.48, 0.113, 159, 115, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR. MUTANT FGF-4-ALA-(23-154) 24 NMR STRUCTURES
538, 3nbcB, 0.5310, 3.49, 0.088, 155, 113, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
539, 4tlvB, 0.5309, 3.53, 0.088, 156, 114, CARDS TOXIN NICKED
540, 4xftB, 0.5307, 3.37, 0.053, 150, 114, STRUCTURE OF IL-18 SER MUTANT III
541, 3nbeA, 0.5302, 3.56, 0.088, 157, 114, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
542, 4tlvA, 0.5295, 3.55, 0.088, 156, 114, CARDS TOXIN NICKED
543, 4x3aA, 0.5292, 3.83, 0.132, 312, 121, GALLUS INTERLEUKIN-1 BETA MUTANT - R140A
544, 4tlvE, 0.5289, 3.34, 0.062, 152, 113, CARDS TOXIN NICKED
545, 4izeA, 0.5286, 3.60, 0.070, 144, 115, CRYSTAL STRUCTURE OF IL-36GAMMA
546, 2x2sC, 0.5286, 3.73, 0.103, 149, 116, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
547, 3nbcA, 0.5280, 3.67, 0.087, 156, 115, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
548, 2j3pA, 0.5280, 2.97, 0.083, 127, 109, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
549, 5xg5A, 0.5279, 3.84, 0.132, 312, 121, CRYSTAL STRUCTURE OF MITSUBA-1 WITH BOUND NACGAL
550, 3nj5A, 0.5279, 3.83, 0.132, 312, 121, CRYSTAL STRUCTURE OF CHICKEN IL-1 HYDROPHOBIC CAVITY MUTANT 157
551, 3f1rB, 0.5278, 3.13, 0.128, 259, 109, CRYSTAL STRUCTURE OF FGF20 DIMER
552, 3f1rA, 0.5278, 3.54, 0.088, 156, 114, CRYSTAL STRUCTURE OF FGF20 DIMER
553, 4eeeB, 0.5276, 3.72, 0.086, 157, 116, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
554, 4j23B, 0.5275, 3.56, 0.088, 156, 114, LOW RESOLUTION CRYSTAL STRUCTURE OF THE FGFR2D2D3/FGF1/SR128545 COMPLEX
555, 3pg0A, 0.5274, 3.38, 0.080, 155, 112, CRYSTAL STRUCTURE OF DESIGNED 3-FOLD SYMMETRIC PROTEIN THREEFOIL
556, 5hn1A, 0.5270, 3.00, 0.092, 125, 109, CRYSTAL STRUCTURE OF INTERLEUKIN-37
557, 1g82A, 0.5269, 3.54, 0.088, 156, 114, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
558, 6ncuB, 0.5262, 3.54, 0.089, 154, 112, INTERLEUKIN-37 RESIDUES 53-206- DIMER 
559, 6ncuA, 0.5260, 3.56, 0.096, 156, 114, INTERLEUKIN-37 RESIDUES 53-206- DIMER 
560, 3ud9A, 0.5258, 2.96, 0.074, 147, 108, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
561, 3nbdA, 0.5258, 3.71, 0.078, 151, 115, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
562, 1g82C, 0.5255, 3.30, 0.090, 148, 111, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
563, 1g82D, 0.5254, 3.72, 0.067, 577, 119, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
564, 1g82B, 0.5252, 3.45, 0.070, 152, 115, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
565, 4xfuA, 0.5248, 3.68, 0.078, 152, 115, STRUCTURE OF IL-18 SER MUTANT V
566, 1ihkA, 0.5247, 3.02, 0.101, 124, 109, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 (FGF9)
567, 3k1xF, 0.5245, 3.36, 0.072, 144, 111, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
568, 4gp0A, 0.5243, 3.18, 0.081, 131, 111, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
569, 6b0tD, 0.5242, 3.30, 0.090, 148, 111, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
570, 3badB, 0.5241, 3.73, 0.067, 580, 119, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
571, 5muaA, 0.5239, 3.52, 0.080, 154, 112, PSL1A-E64 COMPLEX
572, 3o4cA, 0.5238, 3.18, 0.082, 147, 110, CRYSTAL STRUCTURE OF SYMFOIL-4V: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
573, 3k1xC, 0.5234, 3.75, 0.067, 582, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
574, 6b0tE, 0.5232, 3.44, 0.098, 147, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
575, 6b0tB, 0.5232, 3.78, 0.067, 582, 119, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
576, 4xfuB, 0.5232, 3.49, 0.071, 151, 113, STRUCTURE OF IL-18 SER MUTANT V
577, 6i0zB, 0.5230, 3.30, 0.062, 148, 112, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 1 
578, 6i10A, 0.5229, 3.24, 0.073, 148, 110, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 2 
579, 6b0tC, 0.5227, 3.20, 0.090, 134, 111, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
580, 5w59A, 0.5227, 3.15, 0.056, 145, 108, CRYSTAL STRUCTURE OF A MONOMERIC HUMAN FGF9 IN COMPLEX WITH THE ECTODOMAIN OF HUMAN FGFR1C
581, 5muaB, 0.5227, 3.56, 0.088, 152, 113, PSL1A-E64 COMPLEX
582, 4f34A, 0.5227, 3.28, 0.063, 157, 111, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
583, 3ud7B, 0.5227, 3.28, 0.063, 157, 111, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
584, 3p53B, 0.5227, 3.56, 0.099, 147, 111, STRUCTURE OF FASCIN
585, 3h6rB, 0.5225, 3.21, 0.081, 134, 111, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
586, 2ermA, 0.5224, 3.04, 0.065, 140, 108, SOLUTION STRUCTURE OF A BIOLOGICALLY ACTIVE HUMAN FGF-1 MONOMER COMPLEXED TO A HEXASACCHARIDE HEPARIN-ANALOGUE
587, 3q7yA, 0.5223, 3.66, 0.096, 157, 114, CRYSTAL STRUCTURE OF K15R/E18D/Y22W/H41G/F44W/E51D/E53P/K57R/E60D/Y64W/H82G/F85W/E90D/E94P /K98R/E101D/Y108W/H129G/F132W/E137D SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
588, 3jutD, 0.5223, 3.36, 0.071, 157, 112, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
589, 3k1xD, 0.5222, 3.62, 0.088, 154, 114, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
590, 2afgD, 0.5221, 3.39, 0.081, 150, 111, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
591, 3badA, 0.5220, 3.06, 0.101, 128, 109, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
592, 3jutC, 0.5219, 3.25, 0.073, 148, 110, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
593, 6b0tF, 0.5218, 3.43, 0.071, 155, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
594, 4govB, 0.5218, 3.29, 0.072, 155, 111, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
595, 4xkiB, 0.5213, 3.32, 0.072, 157, 111, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
596, 1bldA, 0.5210, 3.60, 0.080, 149, 113, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
597, 3p53A, 0.5207, 3.32, 0.072, 157, 111, STRUCTURE OF FASCIN
598, 3k1xE, 0.5207, 2.99, 0.092, 130, 109, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
599, 1qqlA, 0.5207, 3.06, 0.064, 477, 109, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA
600, 4goyB, 0.5205, 3.11, 0.055, 487, 109, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
601, 4p0lA, 0.5203, 3.00, 0.073, 129, 109, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA WITH ADDITIONAL POINT MUTATIONS
602, 3ud8A, 0.5202, 3.09, 0.036, 269, 110, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
603, 2y9fA, 0.5202, 2.68, 0.105, 124, 105, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR- RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B- TREFOIL LECTIN DOMAIN
604, 4p0kA, 0.5201, 3.08, 0.110, 130, 109, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA
605, 2rq9A, 0.5201, 3.13, 0.055, 487, 109, SOLUTION STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (AFGF) IN THE PRESENCE OF A PROTEIN STABILIZER NDSB-NEW
606, 6b0tA, 0.5200, 3.10, 0.055, 487, 109, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
607, 2j3pB, 0.5200, 3.61, 0.080, 150, 113, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
608, 4q9pA, 0.5199, 3.09, 0.055, 483, 109, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
609, 3o4aC, 0.5198, 3.12, 0.046, 483, 109, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
610, 3o4aB, 0.5198, 3.13, 0.055, 487, 109, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
611, 3ud8B, 0.5197, 3.31, 0.081, 146, 111, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
612, 3zxgB, 0.5196, 3.12, 0.036, 275, 110, LYSENIN SPHINGOMYELIN COMPLEX
613, 3jutA, 0.5196, 2.61, 0.087, 123, 104, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
614, 4xkiA, 0.5195, 3.07, 0.111, 127, 108, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
615, 4f34D, 0.5195, 3.11, 0.055, 484, 109, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
616, 4f34B, 0.5195, 3.49, 0.062, 152, 112, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
617, 3ud7C, 0.5195, 3.18, 0.090, 133, 111, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
618, 3o4dA, 0.5195, 2.72, 0.076, 124, 105, CRYSTAL STRUCTURE OF SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
619, 1barB, 0.5195, 3.10, 0.110, 130, 109, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
620, 3o4aD, 0.5194, 3.11, 0.110, 130, 109, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
621, 3o4aA, 0.5194, 3.05, 0.092, 128, 109, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
622, 4g9mB, 0.5193, 3.08, 0.092, 131, 109, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
623, 3k1xB, 0.5193, 3.09, 0.110, 130, 109, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
624, 5uc6A, 0.5192, 3.13, 0.055, 487, 109, STRUCTURAL INSIGHTS INTO IL-1 ALPHA RECOGNITION BY A NAPHTHYL-MODIFIED APTAMER THAT MIMICS IL-1RI DOMAIN III
625, 1hknD, 0.5192, 3.13, 0.055, 483, 109, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
626, 4d8hA, 0.5190, 3.10, 0.110, 144, 109, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 2 (6XLEU / PV1)
627, 3jutB, 0.5190, 3.08, 0.111, 155, 108, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
628, 3ba4A, 0.5189, 3.12, 0.055, 486, 109, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
629, 4g9nB, 0.5186, 3.07, 0.101, 130, 109, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
630, 3udaB, 0.5186, 3.13, 0.064, 131, 110, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
631, 3q7xA, 0.5186, 3.14, 0.055, 484, 109, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
632, 4yolA, 0.5185, 3.75, 0.078, 143, 115, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
633, 4yolB, 0.5184, 3.06, 0.111, 129, 108, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
634, 3o4bA, 0.5184, 3.33, 0.152, 149, 112, CRYSTAL STRUCTURE OF SYMFOIL-4T: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
635, 2irtB, 0.5184, 3.75, 0.078, 144, 115, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
636, 4jp0A, 0.5183, 3.20, 0.089, 143, 112, CRYSTAL STRUCTURE OF CRY35AB1
637, 3jutF, 0.5183, 3.19, 0.046, 487, 109, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
638, 1nzkD, 0.5183, 3.19, 0.091, 132, 110, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
639, 1jt5B, 0.5183, 3.15, 0.101, 131, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
640, 1blaA, 0.5183, 2.74, 0.077, 123, 104, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
641, 4ow4A, 0.5182, 2.68, 0.087, 123, 104, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
642, 1upsB, 0.5182, 3.08, 0.102, 128, 108, GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS
643, 1nzkB, 0.5182, 3.11, 0.057, 293, 106, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
644, 3k1xA, 0.5181, 3.11, 0.101, 130, 109, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
645, 3h6sF, 0.5181, 3.13, 0.110, 145, 109, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
646, 3ba4B, 0.5181, 2.63, 0.067, 122, 104, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
647, 1jt7D, 0.5181, 2.65, 0.087, 123, 104, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
648, 3fjiD, 0.5180, 3.01, 0.083, 127, 108, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
649, 1jt7B, 0.5180, 2.67, 0.096, 123, 104, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
650, 4izxA, 0.5179, 3.06, 0.092, 138, 109, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH LACTOSE
651, 4ionB, 0.5179, 2.74, 0.077, 123, 104, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
652, 3ojmA, 0.5179, 2.69, 0.087, 123, 104, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING P253R APERT MUTATION
653, 3jutE, 0.5179, 3.23, 0.037, 143, 107, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
654, 3crhB, 0.5179, 3.06, 0.101, 130, 109, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
655, 1hknA, 0.5179, 3.18, 0.083, 151, 108, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
656, 4i4qA, 0.5178, 3.12, 0.110, 129, 109, BEL BETA-TREFOIL APO CRYSTAL FORM 3
657, 2afgC, 0.5178, 2.72, 0.077, 124, 104, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
658, 1ry7A, 0.5178, 3.09, 0.101, 130, 109, CRYSTAL STRUCTURE OF THE 3 IG FORM OF FGFR3C IN COMPLEX WITH FGF1
659, 4ionA, 0.5177, 3.16, 0.091, 144, 110, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
660, 1jt5A, 0.5177, 3.25, 0.037, 143, 107, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
661, 2z49B, 0.5176, 3.10, 0.111, 127, 108, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
662, 2z48B, 0.5176, 2.65, 0.067, 124, 104, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
663, 2z48A, 0.5176, 3.13, 0.119, 143, 109, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
664, 1q1uA, 0.5176, 3.14, 0.119, 143, 109, CRYSTAL STRUCTURE OF HUMAN FHF1B (FGF12B)
665, 4iybB, 0.5175, 2.69, 0.106, 123, 104, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
666, 3b9uA, 0.5175, 3.49, 0.107, 145, 112, CRYSTAL STRUCTURE OF L26N/D28N/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
667, 1hknE, 0.5175, 3.31, 0.091, 378, 110, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
668, 1ytoB, 0.5173, 3.13, 0.110, 130, 109, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
669, 1iraX, 0.5173, 3.09, 0.093, 141, 108, COMPLEX OF THE INTERLEUKIN-1 RECEPTOR WITH THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA)
670, 3fjiC, 0.5172, 3.07, 0.102, 142, 108, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
671, 1md6A, 0.5172, 3.10, 0.111, 155, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF MURINE IL-1F5 REVEALS UNIQUE LOOP CONFORMATION FOR SPECIFICITY
672, 3ud9B, 0.5171, 2.63, 0.107, 123, 103, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
673, 1k5uA, 0.5171, 3.06, 0.057, 397, 105, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
674, 2axmA, 0.5170, 3.10, 0.093, 141, 108, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
675, 1ytoD, 0.5170, 3.13, 0.110, 130, 109, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
676, 1q03A, 0.5170, 3.38, 0.064, 150, 110, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
677, 1jt7C, 0.5170, 3.15, 0.091, 144, 110, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
678, 4qksA, 0.5169, 3.09, 0.093, 142, 108, CRYSTAL STRUCTURE OF 6XTRP/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22W/L44W/L64W/L85W/L108W/L132W HIS PRIMITIVE VERSION 2)
679, 4j2sA, 0.5169, 3.03, 0.083, 139, 108, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH DI- LACNAC
680, 4cjmA, 0.5169, 3.09, 0.093, 142, 108, CRYSTAL STRUCTURE OF HUMAN FGF18
681, 1vclA, 0.5169, 2.95, 0.057, 139, 105, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
682, 1q03B, 0.5169, 3.07, 0.057, 140, 106, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
683, 4lo8H, 0.5168, 3.23, 0.091, 145, 110, HA70(D3)-HA17
684, 4lo8F, 0.5168, 3.13, 0.083, 130, 109, HA70(D3)-HA17
685, 3udaC, 0.5168, 3.06, 0.102, 142, 108, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
686, 3halA, 0.5168, 3.08, 0.102, 128, 108, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
687, 3crhA, 0.5168, 3.48, 0.082, 146, 110, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
688, 2z49A, 0.5168, 3.04, 0.093, 127, 108, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
689, 1nzkA, 0.5168, 3.39, 0.090, 151, 111, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
690, 4qalA, 0.5167, 2.95, 0.057, 140, 105, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
691, 3fjkD, 0.5167, 3.08, 0.102, 142, 108, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
692, 3f62B, 0.5167, 3.49, 0.062, 431, 112, CRYSTAL STRUCTURE OF HUMAN IL-18 IN COMPLEX WITH ECTROMELIA VIRUS IL- 18 BINDING PROTEIN
693, 1ytoA, 0.5167, 3.49, 0.062, 431, 112, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
694, 1vclB, 0.5167, 3.49, 0.062, 431, 112, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
695, 1jt7A, 0.5167, 3.29, 0.091, 138, 110, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
696, 4iybA, 0.5166, 3.07, 0.057, 140, 106, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
697, 3ud8C, 0.5166, 3.15, 0.101, 132, 109, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
698, 2afgA, 0.5166, 3.11, 0.092, 130, 109, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
699, 1ytoC, 0.5166, 3.08, 0.102, 141, 108, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
700, 1jtcC, 0.5166, 3.66, 0.106, 145, 113, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
701, 3halB, 0.5165, 3.08, 0.102, 142, 108, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
702, 2aqzB, 0.5165, 3.89, 0.096, 154, 115, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
703, 1jtcA, 0.5164, 3.02, 0.083, 128, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
704, 1jt3A, 0.5164, 3.14, 0.119, 129, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
705, 1hknB, 0.5164, 3.14, 0.102, 130, 108, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
706, 4lo8D, 0.5163, 3.10, 0.102, 138, 108, HA70(D3)-HA17
707, 3q7wA, 0.5163, 3.12, 0.092, 141, 109, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
708, 5mvzU, 0.5162, 3.05, 0.074, 141, 108, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
709, 4lo8B, 0.5162, 2.75, 0.078, 124, 103, HA70(D3)-HA17
710, 3criA, 0.5162, 2.96, 0.057, 139, 105, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
711, 2irtA, 0.5162, 3.13, 0.083, 129, 108, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
712, 2hz9A, 0.5162, 3.51, 0.062, 431, 112, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
713, 1nunA, 0.5162, 3.10, 0.101, 141, 109, CRYSTAL STRUCTURE ANALYSIS OF THE FGF10-FGFR2B COMPLEX
714, 4qc4A, 0.5161, 3.45, 0.073, 143, 110, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
715, 4p0jB, 0.5161, 3.51, 0.064, 142, 110, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
716, 4f34C, 0.5161, 3.14, 0.101, 129, 109, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
717, 2hz9B, 0.5161, 3.08, 0.102, 131, 108, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
718, 2aqzA, 0.5161, 3.09, 0.102, 142, 108, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
719, 1nzkC, 0.5161, 3.52, 0.062, 431, 112, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
720, 1m16B, 0.5161, 3.07, 0.074, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
721, 1jt3B, 0.5161, 3.14, 0.110, 142, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
722, 4qkrA, 0.5160, 3.08, 0.102, 141, 108, CRYSTAL STRUCTURE OF 6XTYR/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22Y/L44Y/L64Y/L85Y/L108Y/L132Y PRIMITIVE VERSION 2)
723, 4jpzE, 0.5160, 3.64, 0.109, 145, 110, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
724, 2afgB, 0.5160, 3.10, 0.102, 139, 108, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
725, 1p63A, 0.5159, 3.52, 0.062, 431, 112, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
726, 4q9pB, 0.5158, 3.10, 0.093, 141, 108, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
727, 2ntdC, 0.5158, 2.99, 0.057, 140, 106, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
728, 1m16A, 0.5158, 3.18, 0.110, 129, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
729, 1k5uC, 0.5158, 3.16, 0.110, 129, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
730, 1jt4A, 0.5158, 3.10, 0.102, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
731, 3fjbA, 0.5157, 3.10, 0.093, 141, 108, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
732, 3criB, 0.5157, 3.10, 0.102, 131, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
733, 4qc4B, 0.5156, 3.04, 0.083, 141, 108, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
734, 4qbvA, 0.5156, 3.10, 0.093, 141, 108, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
735, 4p0jA, 0.5156, 3.10, 0.102, 143, 108, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
736, 2hwmA, 0.5156, 3.13, 0.111, 128, 108, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
737, 3h6sG, 0.5155, 3.52, 0.064, 143, 110, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
738, 4jpzA, 0.5154, 2.74, 0.067, 124, 104, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
739, 2ntdD, 0.5154, 3.56, 0.064, 136, 110, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
740, 2f2fA, 0.5154, 3.52, 0.055, 143, 110, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
741, 1p63B, 0.5154, 3.11, 0.102, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
742, 1barA, 0.5154, 3.52, 0.107, 145, 112, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
743, 4qo3A, 0.5153, 3.09, 0.102, 141, 108, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
744, 4q9gA, 0.5153, 3.24, 0.055, 139, 109, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
745, 3fjkA, 0.5153, 3.11, 0.111, 141, 108, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
746, 3bahA, 0.5153, 3.77, 0.079, 147, 114, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
747, 1jtcD, 0.5153, 2.75, 0.067, 124, 104, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
748, 1jt4B, 0.5153, 3.10, 0.102, 142, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
749, 1jqzA, 0.5153, 3.05, 0.083, 140, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
750, 3fjiB, 0.5152, 3.11, 0.093, 141, 108, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
751, 3fjiA, 0.5152, 3.05, 0.083, 142, 108, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
752, 3fjbB, 0.5152, 3.04, 0.083, 142, 108, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
753, 3fj9B, 0.5152, 2.77, 0.087, 125, 104, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
754, 3cqaA, 0.5152, 3.63, 0.080, 148, 113, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
755, 2hwaA, 0.5152, 3.19, 0.119, 129, 109, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
756, 1jtcB, 0.5152, 3.11, 0.102, 140, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
757, 1afcB, 0.5152, 3.05, 0.093, 140, 108, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
758, 5bquC, 0.5151, 3.11, 0.111, 142, 108, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
759, 3fjfB, 0.5151, 3.12, 0.093, 142, 108, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
760, 3bagA, 0.5151, 3.21, 0.110, 129, 109, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
761, 2ntdB, 0.5151, 3.11, 0.102, 141, 108, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
762, 1jqzB, 0.5151, 3.11, 0.093, 140, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
763, 1axmE, 0.5151, 3.05, 0.093, 142, 108, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
764, 4ekxB, 0.5150, 3.11, 0.102, 141, 108, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
765, 3zxgA, 0.5150, 3.11, 0.111, 141, 108, LYSENIN SPHINGOMYELIN COMPLEX
766, 1axmA, 0.5150, 3.77, 0.079, 147, 114, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
767, 3homA, 0.5149, 3.11, 0.102, 141, 108, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
768, 2hw9A, 0.5149, 3.30, 0.073, 150, 109, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
769, 2fgfA, 0.5149, 3.50, 0.071, 148, 112, THREE-DIMENSIONAL STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR A STRUCTURAL HOMOLOG OF INTERLEUKIN 1BETA
770, 1q04B, 0.5149, 3.12, 0.102, 142, 108, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
771, 1q04A, 0.5149, 3.68, 0.071, 153, 112, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
772, 3udaA, 0.5148, 3.11, 0.111, 141, 108, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
773, 3hbwA, 0.5148, 3.10, 0.102, 127, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
774, 3fjdA, 0.5148, 3.19, 0.119, 142, 109, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
775, 3bahB, 0.5148, 3.12, 0.111, 142, 108, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
776, 3ba5A, 0.5148, 3.10, 0.102, 142, 108, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
777, 1k5vA, 0.5148, 3.11, 0.102, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
778, 4qbcA, 0.5147, 3.11, 0.093, 141, 108, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
779, 4lo1C, 0.5147, 3.12, 0.111, 141, 108, HA17-HA33-GAL
780, 3hbwB, 0.5147, 3.11, 0.102, 141, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
781, 5bp5C, 0.5146, 3.06, 0.083, 142, 108, CRYSTAL STRUCTURE OF HA17-HA33-IPT
782, 4qalB, 0.5146, 3.05, 0.083, 140, 108, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
783, 4lo3C, 0.5146, 3.06, 0.074, 140, 108, HA17-HA33-LACNAC
784, 3ud7A, 0.5146, 3.06, 0.083, 141, 108, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
785, 3o49A, 0.5146, 3.12, 0.102, 140, 108, CRYSTAL STRUCTURE OF SYMFOIL-1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
786, 3fjeA, 0.5146, 3.10, 0.102, 140, 108, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
787, 3fj9A, 0.5146, 3.12, 0.093, 141, 108, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
788, 2y9gA, 0.5146, 3.05, 0.103, 127, 107, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR-RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B-TREFOIL LECTIN DOMAIN
789, 4qbvB, 0.5145, 3.41, 0.073, 144, 110, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
790, 4q91B, 0.5145, 3.06, 0.093, 142, 108, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
791, 4lo7G, 0.5145, 3.11, 0.102, 141, 108, HA70(D3)-HA17-HA33
792, 4lo7C, 0.5145, 3.13, 0.102, 143, 108, HA70(D3)-HA17-HA33
793, 4lo0C, 0.5145, 3.11, 0.102, 141, 108, APO HA17-HA33
794, 3bb2A, 0.5145, 3.13, 0.083, 128, 108, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
795, 1rg8A, 0.5145, 3.60, 0.092, 142, 109, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
796, 1jy0A, 0.5145, 3.12, 0.057, 293, 105, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
797, 1hknF, 0.5145, 3.17, 0.102, 129, 108, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
798, 3homB, 0.5144, 3.11, 0.102, 141, 108, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
799, 3cqaB, 0.5144, 3.11, 0.102, 141, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
800, 3bauA, 0.5144, 2.99, 0.113, 126, 106, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
801, 3baqA, 0.5144, 3.12, 0.093, 141, 108, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
802, 3baoA, 0.5144, 3.12, 0.093, 141, 108, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
803, 4q91A, 0.5143, 3.02, 0.084, 126, 107, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
804, 3ba7B, 0.5143, 3.33, 0.082, 149, 110, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
805, 3ba7A, 0.5143, 3.12, 0.093, 141, 108, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
806, 2e4mC, 0.5143, 3.14, 0.111, 142, 108, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
807, 1rg8B, 0.5143, 3.12, 0.102, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
808, 1pzzA, 0.5143, 3.13, 0.111, 128, 108, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
809, 1ilr1, 0.5143, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
810, 1afcF, 0.5143, 3.48, 0.064, 144, 110, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
811, 3fjeB, 0.5142, 3.33, 0.082, 149, 110, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
812, 2q9xA, 0.5142, 3.41, 0.073, 144, 110, CRYSTAL STRUCTURE OF HIGHLY STABLE MUTANT Q40P/S47I/H93G OF HUMAN FIBROBLAST GROWTH FACTOR-1
813, 2ntdA, 0.5142, 3.13, 0.111, 141, 108, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
814, 1hknC, 0.5142, 3.41, 0.073, 144, 110, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
815, 4dckC, 0.5141, 3.12, 0.102, 127, 108, CRYSTAL STRUCTURE OF THE C-TERMINUS OF VOLTAGE-GATED SODIUM CHANNEL IN COMPLEX WITH FGF13 AND CAM
816, 3fjdB, 0.5141, 2.79, 0.078, 123, 103, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
817, 3crgB, 0.5141, 3.13, 0.111, 141, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
818, 3crgA, 0.5141, 3.11, 0.093, 141, 108, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
819, 2hwaB, 0.5141, 3.48, 0.152, 147, 112, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
820, 1k5uB, 0.5141, 3.12, 0.102, 141, 108, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
821, 3fjkC, 0.5140, 3.13, 0.111, 142, 108, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
822, 3fjhB, 0.5140, 3.48, 0.064, 139, 110, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
823, 3fjcA, 0.5140, 3.49, 0.064, 139, 110, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
824, 3bavA, 0.5140, 3.48, 0.064, 144, 110, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
825, 3bauB, 0.5140, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
826, 1qqkA, 0.5140, 3.11, 0.102, 141, 108, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR)
827, 1e0oA, 0.5140, 3.11, 0.102, 140, 108, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
828, 4qd2G, 0.5139, 3.04, 0.093, 128, 108, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
829, 4lo2C, 0.5139, 3.12, 0.111, 141, 108, HA17-HA33-LAC
830, 3bagB, 0.5139, 3.07, 0.083, 141, 108, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
831, 2hwmB, 0.5139, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
832, 4qbcB, 0.5138, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
833, 3oj2B, 0.5138, 3.13, 0.111, 141, 108, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
834, 3oj2A, 0.5138, 3.13, 0.111, 141, 108, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
835, 3fjhA, 0.5138, 3.14, 0.111, 141, 108, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
836, 4q9gB, 0.5137, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
837, 3o3qC, 0.5137, 3.34, 0.046, 143, 109, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
838, 3fjfA, 0.5137, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
839, 3baoB, 0.5137, 3.13, 0.093, 140, 108, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
840, 4ow4B, 0.5136, 3.62, 0.106, 145, 113, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
841, 3zxdB, 0.5136, 3.07, 0.103, 127, 107, WILD-TYPE LYSENIN
842, 3fjjB, 0.5136, 3.13, 0.102, 141, 108, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
843, 3fjaA, 0.5136, 3.09, 0.102, 127, 108, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
844, 1pzzB, 0.5136, 3.12, 0.111, 142, 108, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
845, 1afcG, 0.5136, 3.10, 0.102, 129, 108, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
846, 3fjcB, 0.5135, 3.55, 0.080, 148, 112, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
847, 3fj8A, 0.5135, 3.14, 0.102, 141, 108, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
848, 3ba5B, 0.5135, 3.14, 0.102, 141, 108, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
849, 3h6sE, 0.5134, 3.13, 0.102, 141, 108, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
850, 3bb2B, 0.5134, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
851, 5ec5A, 0.5133, 3.19, 0.119, 128, 109, CRYSTAL STRUCTURE OF LYSENIN PORE
852, 3fjaB, 0.5133, 3.07, 0.083, 141, 108, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
853, 2hw9B, 0.5133, 3.14, 0.111, 141, 108, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
854, 1z4sD, 0.5133, 3.13, 0.093, 141, 108, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
855, 1bffA, 0.5133, 3.12, 0.102, 141, 108, THE 154 AMINO ACID FORM OF HUMAN BASIC FIBROBLAST GROWTH FACTOR
856, 4cjmD, 0.5132, 3.14, 0.111, 141, 108, CRYSTAL STRUCTURE OF HUMAN FGF18
857, 3bavB, 0.5132, 3.08, 0.074, 129, 108, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
858, 1z4sC, 0.5132, 3.20, 0.119, 129, 109, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
859, 1afcD, 0.5132, 3.56, 0.064, 143, 110, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
860, 4i4uB, 0.5131, 3.49, 0.055, 144, 110, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
861, 2axmB, 0.5131, 3.08, 0.083, 141, 108, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
862, 1iltA, 0.5131, 3.13, 0.102, 141, 108, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
863, 1iilA, 0.5131, 3.13, 0.102, 142, 108, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
864, 6i15A, 0.5130, 3.21, 0.101, 135, 109, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 11 
865, 3ud9C, 0.5130, 3.21, 0.101, 135, 109, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
866, 3fjjA, 0.5130, 3.14, 0.102, 141, 108, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
867, 2f2fD, 0.5129, 3.14, 0.111, 142, 108, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
868, 3zxdA, 0.5128, 2.95, 0.105, 127, 105, WILD-TYPE LYSENIN
869, 3cu1D, 0.5128, 3.12, 0.102, 141, 108, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
870, 2uusB, 0.5128, 3.13, 0.102, 142, 108, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
871, 1jy0B, 0.5128, 2.70, 0.107, 123, 103, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
872, 1iilC, 0.5128, 3.17, 0.075, 294, 106, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
873, 1afcC, 0.5128, 3.07, 0.083, 141, 108, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
874, 5x1oB, 0.5127, 3.13, 0.111, 141, 108, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
875, 4cjmB, 0.5127, 3.14, 0.102, 142, 108, CRYSTAL STRUCTURE OF HUMAN FGF18
876, 3fjkB, 0.5127, 3.06, 0.103, 127, 107, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
877, 2fdbM, 0.5127, 3.14, 0.093, 141, 108, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
878, 1z4sB, 0.5127, 3.13, 0.111, 141, 108, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
879, 1axmF, 0.5127, 3.14, 0.111, 141, 108, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
880, 4i4yA, 0.5126, 3.30, 0.073, 150, 109, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
881, 4eeeD, 0.5126, 3.15, 0.111, 141, 108, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
882, 3h6rA, 0.5126, 3.12, 0.076, 290, 105, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
883, 3fj8B, 0.5126, 3.07, 0.083, 141, 108, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
884, 3fgmA, 0.5126, 3.14, 0.102, 141, 108, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
885, 3baqB, 0.5126, 3.01, 0.084, 137, 107, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
886, 4qd2B, 0.5125, 3.11, 0.120, 129, 108, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
887, 4i4vB, 0.5125, 3.09, 0.084, 129, 107, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
888, 3fgmB, 0.5124, 3.14, 0.111, 141, 108, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
889, 4jq0A, 0.5123, 3.06, 0.103, 140, 107, VOLTAGE-GATED SODIUM CHANNEL 1.5 C-TERMINAL DOMAIN IN COMPLEX WITH FGF12B AND CA2+/CALMODULIN
890, 4g9mA, 0.5123, 3.08, 0.103, 127, 107, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
891, 4cjmC, 0.5123, 3.34, 0.073, 146, 110, CRYSTAL STRUCTURE OF HUMAN FGF18
892, 3llpA, 0.5123, 3.16, 0.093, 127, 108, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
893, 4qo3B, 0.5122, 3.65, 0.106, 143, 113, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
894, 1z4sA, 0.5122, 3.17, 0.102, 134, 108, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
895, 1iltB, 0.5122, 2.78, 0.039, 484, 103, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
896, 1djsB, 0.5122, 3.05, 0.093, 127, 107, LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1
897, 4i4yD, 0.5119, 3.13, 0.102, 141, 108, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
898, 4g9nA, 0.5119, 3.71, 0.062, 153, 112, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
899, 4i4xB, 0.5118, 3.15, 0.066, 293, 106, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
900, 1e0oC, 0.5118, 3.08, 0.093, 131, 108, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
901, 1afcH, 0.5118, 3.04, 0.075, 129, 107, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
902, 4i4rC, 0.5117, 3.15, 0.111, 141, 108, BEL BETA-TREFOIL APO CRYSTAL FORM 4
903, 3o3qD, 0.5117, 3.18, 0.111, 132, 108, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
904, 2uusA, 0.5117, 3.05, 0.103, 127, 107, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
905, 2bfhA, 0.5117, 3.04, 0.123, 127, 106, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
906, 4i4yB, 0.5116, 3.12, 0.084, 128, 107, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
907, 3ojvA, 0.5116, 3.09, 0.083, 141, 108, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
908, 1ii4C, 0.5116, 3.19, 0.055, 149, 109, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
909, 4tlvF, 0.5115, 3.06, 0.103, 140, 107, CARDS TOXIN NICKED
910, 3ojvB, 0.5115, 3.17, 0.111, 128, 108, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
911, 1ii4D, 0.5115, 3.72, 0.099, 146, 111, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
912, 6i13A, 0.5114, 3.29, 0.085, 141, 106, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 7 
913, 1ii4B, 0.5114, 3.52, 0.055, 152, 110, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
914, 1ii4A, 0.5114, 3.16, 0.120, 141, 108, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
915, 4i4uC, 0.5113, 3.14, 0.093, 141, 108, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
916, 1iilD, 0.5113, 3.15, 0.111, 141, 108, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
917, 1ev2C, 0.5113, 3.57, 0.055, 143, 110, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
918, 4i4xD, 0.5112, 3.35, 0.073, 146, 110, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
919, 1ev2D, 0.5112, 3.10, 0.083, 141, 108, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
920, 1iilB, 0.5111, 3.55, 0.072, 141, 111, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
921, 1ev2B, 0.5111, 3.28, 0.038, 142, 106, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
922, 1ev2A, 0.5111, 3.10, 0.084, 128, 107, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
923, 4i4rB, 0.5110, 2.90, 0.058, 472, 104, BEL BETA-TREFOIL APO CRYSTAL FORM 4
924, 4i4oA, 0.5110, 3.16, 0.111, 141, 108, BEL BETA-TREFOIL APO CRYSTAL FORM 1
925, 1afcE, 0.5110, 3.02, 0.084, 138, 107, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
926, 1bfbA, 0.5109, 3.74, 0.097, 143, 113, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN TETRAMER FRAGMENT
927, 1afcA, 0.5109, 3.35, 0.109, 134, 110, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
928, 1evtA, 0.5108, 3.75, 0.062, 146, 113, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
929, 4i4pB, 0.5107, 3.29, 0.038, 142, 106, BEL BETA-TREFOIL APO CRYSTAL FORM 2
930, 1evtB, 0.5107, 3.62, 0.062, 146, 112, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
931, 6i12A, 0.5106, 3.22, 0.119, 130, 109, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 5 
932, 4gaiB, 0.5106, 3.07, 0.103, 127, 107, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
933, 4i4uA, 0.5105, 3.52, 0.072, 146, 111, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
934, 3w9tD, 0.5105, 2.95, 0.086, 127, 105, PORE-FORMING CEL-III
935, 5x1oA, 0.5104, 3.08, 0.084, 131, 107, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
936, 4i4uD, 0.5104, 3.23, 0.102, 128, 108, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
937, 1ilr2, 0.5104, 3.63, 0.062, 146, 112, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
938, 1fq9A, 0.5104, 3.23, 0.119, 133, 109, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
939, 6i11A, 0.5103, 3.09, 0.103, 134, 107, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 3 
940, 4tlwA, 0.5103, 4.06, 0.060, 573, 116, CARDS TOXIN FULL-LENGTH
941, 4i4vA, 0.5103, 3.23, 0.119, 133, 109, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
942, 4iy8A, 0.5102, 3.09, 0.103, 134, 107, BMLP3 - P21 CRYSTAL FORM
943, 4i4sD, 0.5102, 2.80, 0.039, 484, 103, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
944, 4i4oB, 0.5102, 3.09, 0.103, 134, 107, BEL BETA-TREFOIL APO CRYSTAL FORM 1
945, 2fdbN, 0.5102, 3.09, 0.103, 134, 107, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
946, 6i18A, 0.5101, 3.55, 0.072, 146, 111, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH BDP-13176 
947, 3o3qA, 0.5101, 3.08, 0.112, 132, 107, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
948, 1z2vB, 0.5101, 3.08, 0.103, 130, 107, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
949, 1fq9B, 0.5101, 3.62, 0.062, 146, 112, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
950, 6i14A, 0.5100, 3.08, 0.103, 130, 107, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 9 
951, 4i4vC, 0.5100, 3.08, 0.112, 133, 107, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
952, 5gaqI, 0.5099, 3.08, 0.103, 130, 107, CRYO-EM STRUCTURE OF THE LYSENIN PORE
953, 5gaqH, 0.5099, 3.08, 0.103, 130, 107, CRYO-EM STRUCTURE OF THE LYSENIN PORE
954, 5gaqG, 0.5099, 3.62, 0.071, 146, 112, CRYO-EM STRUCTURE OF THE LYSENIN PORE
955, 5gaqF, 0.5099, 3.75, 0.071, 146, 113, CRYO-EM STRUCTURE OF THE LYSENIN PORE
956, 5gaqE, 0.5099, 3.08, 0.103, 127, 107, CRYO-EM STRUCTURE OF THE LYSENIN PORE
957, 5gaqD, 0.5099, 2.98, 0.114, 124, 105, CRYO-EM STRUCTURE OF THE LYSENIN PORE
958, 5gaqC, 0.5099, 3.08, 0.103, 127, 107, CRYO-EM STRUCTURE OF THE LYSENIN PORE
959, 5gaqB, 0.5099, 3.25, 0.119, 131, 109, CRYO-EM STRUCTURE OF THE LYSENIN PORE
960, 5gaqA, 0.5099, 3.56, 0.063, 146, 111, CRYO-EM STRUCTURE OF THE LYSENIN PORE
961, 3w9tB, 0.5099, 3.25, 0.119, 131, 109, PORE-FORMING CEL-III
962, 3n0kA, 0.5098, 2.80, 0.039, 484, 103, PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
963, 6i16A, 0.5097, 3.51, 0.028, 140, 108, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 15 
964, 3cu1B, 0.5097, 3.39, 0.073, 146, 110, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
965, 4i4sA, 0.5096, 3.87, 0.070, 431, 114, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
966, 1z2vA, 0.5096, 3.05, 0.123, 127, 106, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
967, 4i4vD, 0.5095, 3.54, 0.072, 146, 111, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
968, 4i4rD, 0.5095, 3.80, 0.105, 144, 114, BEL BETA-TREFOIL APO CRYSTAL FORM 4
969, 4i4xC, 0.5094, 3.02, 0.104, 129, 106, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
970, 6i0zA, 0.5093, 2.81, 0.039, 484, 103, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 1 
971, 4i4xA, 0.5092, 4.07, 0.060, 567, 116, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
972, 6i17A, 0.5090, 3.39, 0.073, 146, 110, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 24 
973, 4i4rA, 0.5090, 3.34, 0.056, 239, 108, BEL BETA-TREFOIL APO CRYSTAL FORM 4
974, 3w9tC, 0.5090, 3.53, 0.072, 146, 111, PORE-FORMING CEL-III
975, 4i4yC, 0.5089, 3.77, 0.062, 146, 113, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
976, 2m49C, 0.5089, 3.15, 0.056, 148, 108, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
977, 2ilaA, 0.5089, 2.82, 0.039, 484, 103, STRUCTURE OF INTERLEUKIN 1ALPHA AT 2.7-ANGSTROMS RESOLUTION
978, 1dfcB, 0.5088, 2.78, 0.068, 123, 103, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
979, 5ec5R, 0.5086, 3.10, 0.103, 140, 107, CRYSTAL STRUCTURE OF LYSENIN PORE
980, 5ec5N, 0.5086, 3.02, 0.104, 129, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
981, 4i4sC, 0.5086, 2.81, 0.039, 484, 103, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
982, 3zxdC, 0.5085, 3.78, 0.062, 146, 113, WILD-TYPE LYSENIN
983, 3w9tF, 0.5085, 3.29, 0.075, 288, 106, PORE-FORMING CEL-III
984, 2m49A, 0.5085, 3.29, 0.075, 288, 106, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
985, 5ec5P, 0.5084, 3.29, 0.075, 288, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
986, 5hn1B, 0.5083, 3.29, 0.075, 288, 106, CRYSTAL STRUCTURE OF INTERLEUKIN-37
987, 4i4sB, 0.5083, 3.29, 0.075, 288, 106, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
988, 3w9tE, 0.5083, 3.29, 0.075, 288, 106, PORE-FORMING CEL-III
989, 5ec5M, 0.5082, 3.29, 0.075, 288, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
990, 4i4pA, 0.5081, 3.29, 0.075, 288, 106, BEL BETA-TREFOIL APO CRYSTAL FORM 2
991, 1dfcA, 0.5081, 3.29, 0.075, 288, 106, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
992, 1axmB, 0.5080, 3.92, 0.070, 431, 114, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
993, 5ec5F, 0.5079, 3.18, 0.065, 150, 108, CRYSTAL STRUCTURE OF LYSENIN PORE
994, 4tlvD, 0.5079, 2.82, 0.039, 484, 103, CARDS TOXIN NICKED
995, 3w9tG, 0.5079, 3.14, 0.102, 128, 108, PORE-FORMING CEL-III
996, 1bfgA, 0.5076, 3.54, 0.072, 146, 111, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
997, 5ec5B, 0.5075, 3.11, 0.103, 140, 107, CRYSTAL STRUCTURE OF LYSENIN PORE
998, 1axmD, 0.5075, 3.78, 0.062, 146, 113, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
999, 5ec5G, 0.5074, 3.72, 0.054, 146, 112, CRYSTAL STRUCTURE OF LYSENIN PORE
1000, 3h6sH, 0.5074, 3.57, 0.072, 146, 111, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1001, 1axmC, 0.5073, 2.87, 0.049, 484, 103, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1002, 5ec5L, 0.5071, 3.67, 0.062, 146, 112, CRYSTAL STRUCTURE OF LYSENIN PORE
1003, 5ec5K, 0.5071, 2.84, 0.039, 484, 103, CRYSTAL STRUCTURE OF LYSENIN PORE
1004, 5ec5J, 0.5071, 3.66, 0.071, 146, 112, CRYSTAL STRUCTURE OF LYSENIN PORE
1005, 5ec5C, 0.5071, 3.90, 0.070, 431, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1006, 5ec5S, 0.5070, 3.80, 0.062, 146, 113, CRYSTAL STRUCTURE OF LYSENIN PORE
1007, 1k5vB, 0.5070, 3.02, 0.123, 126, 106, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
1008, 3winC, 0.5069, 3.18, 0.085, 145, 106, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
1009, 1bfcA, 0.5069, 2.86, 0.039, 474, 103, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN HEXAMER FRAGMENT
1010, 5ec5E, 0.5068, 3.27, 0.066, 283, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
1011, 5ec5O, 0.5067, 3.32, 0.075, 289, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
1012, 5ec5H, 0.5067, 3.68, 0.062, 146, 112, CRYSTAL STRUCTURE OF LYSENIN PORE
1013, 5ec5I, 0.5065, 3.31, 0.075, 290, 106, CRYSTAL STRUCTURE OF LYSENIN PORE
1014, 5ec5D, 0.5065, 3.88, 0.070, 431, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1015, 6bfmA, 0.5058, 3.03, 0.123, 126, 106, GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS; ISOFORM1 
1016, 3w9tA, 0.5057, 3.32, 0.075, 289, 106, PORE-FORMING CEL-III
1017, 4i8mA, 0.5054, 3.61, 0.082, 149, 110, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT V219I
1018, 4iy8D, 0.5052, 3.77, 0.071, 146, 113, BMLP3 - P21 CRYSTAL FORM
1019, 4oefA, 0.5051, 3.86, 0.070, 431, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S6I2) COMPLEX
1020, 3wmvB, 0.5050, 3.32, 0.075, 289, 106, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC WITH LIGAND FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
1021, 1ijtA, 0.5049, 3.77, 0.071, 146, 113, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 4 (FGF4)
1022, 4gp3A, 0.5047, 2.87, 0.039, 475, 103, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1023, 4goyA, 0.5047, 3.14, 0.084, 126, 107, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1024, 5f90B, 0.5045, 3.28, 0.066, 283, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GB3 ALLYL
1025, 4oegA, 0.5045, 3.95, 0.034, 577, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S9I2) COMPLEX
1026, 3o3qB, 0.5044, 3.89, 0.070, 431, 114, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1027, 1sr4A, 0.5043, 3.07, 0.104, 126, 106, CRYSTAL STRUCTURE OF THE HAEMOPHILUS DUCREYI CYTOLETHAL DISTENDING TOXIN
1028, 4oeeA, 0.5042, 3.27, 0.066, 284, 106, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S3I2) COMPLEX
1029, 2yugA, 0.5042, 3.16, 0.093, 126, 107, SOLUTION STRUCTURE OF MOUSE FRG1 PROTEIN
1030, 2ki6E, 0.5042, 3.30, 0.066, 290, 106, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1031, 2ki4D, 0.5042, 3.31, 0.075, 150, 107, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1032, 5f8wB, 0.5041, 3.18, 0.084, 127, 107, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
1033, 5f8sA, 0.5041, 3.29, 0.066, 284, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
1034, 5f8yB, 0.5039, 3.29, 0.066, 290, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
1035, 5f8yA, 0.5039, 3.28, 0.066, 290, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
1036, 5f8wA, 0.5038, 3.34, 0.075, 286, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
1037, 4owlD, 0.5035, 3.29, 0.075, 283, 106, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
1038, 4fgfA, 0.5034, 3.12, 0.113, 126, 106, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
1039, 3wmuB, 0.5033, 3.48, 0.064, 141, 109, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC APO-FORM FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
1040, 3zxdD, 0.5031, 3.00, 0.114, 124, 105, WILD-TYPE LYSENIN
1041, 1fgaA, 0.5030, 3.30, 0.066, 283, 106, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
1042, 5f8sB, 0.5029, 3.36, 0.075, 289, 106, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
1043, 1basA, 0.5029, 3.30, 0.066, 283, 106, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
1044, 2k4aB, 0.5028, 3.29, 0.066, 282, 106, FGF-1-C2A BINARY COMPLEX STRUCTURE: A KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
1045, 4i3nA, 0.5027, 3.30, 0.066, 285, 106, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT D61N
1046, 2kkiA, 0.5026, 3.67, 0.055, 150, 109, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN 1A
1047, 4owkE, 0.5025, 3.92, 0.070, 431, 114, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
1048, 2ki6B, 0.5024, 3.31, 0.065, 480, 107, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1049, 2ki4A, 0.5024, 3.39, 0.056, 239, 108, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1050, 6bfmB, 0.5022, 3.03, 0.105, 125, 105, GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS; ISOFORM1 
1051, 3im5A, 0.5022, 3.68, 0.055, 149, 109, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
1052, 5y97C, 0.5021, 3.04, 0.077, 128, 104, CRYSTAL STRUCTURE OF SNAKE GOURD SEED LECTIN IN COMPLEX WITH LACTOSE 
1053, 4govA, 0.5020, 2.87, 0.039, 480, 103, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1054, 2l5xA, 0.5019, 2.88, 0.039, 475, 103, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1055, 5y42F, 0.5012, 3.71, 0.064, 149, 109, NATIVE-CRYSTAL STRUCTURE OF THREE CHAIN NON-TOXIC TYPE II RIBOSOME INACTIVATING PROTEIN PURIFIED FROM THE SEEDS OF TRICHOSANTHES ANGUINA 
1056, 4iy8B, 0.5012, 3.04, 0.105, 124, 105, BMLP3 - P21 CRYSTAL FORM
1057, 2l5xD, 0.5011, 2.80, 0.069, 122, 102, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1058, 3vwcA, 0.5009, 3.88, 0.052, 167, 115, HIGH RESOLUTION STRUCTURE OF PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
1059, 3zx7A, 0.5004, 3.06, 0.105, 132, 105, COMPLEX OF LYSENIN WITH PHOSPHOCHOLINE
1060, 4gp3B, 0.5002, 3.02, 0.048, 155, 104, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1061, 2mc2A, 0.5002, 3.25, 0.110, 133, 109, X-RAY CRYSTALLOGRAPHY-SOLUTION NMR HYBRID STRUCTURE OF MOUSE RYR2 DOMAIN A
